Mechanism of regulation of Down Regulated Adenoma (DRA) in obesity associated colitis induced colon cancer
下调腺瘤(DRA)在肥胖相关性结肠炎诱发结肠癌中的调节机制
基本信息
- 批准号:10651008
- 负责人:
- 金额:$ 15.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcidsAddressAdipocytesAdipose tissueAffinityAgeAnimal ModelAnimalsAnionsAppalachian RegionAzoxymethaneBackBicarbonatesBody WeightBuffersCaco-2 CellsCaloriesCancer ModelCarbon DioxideCase StudyCell LineCellsCenters of Research ExcellenceCentrifugationChloridesClinicalColitisColitis associated colorectal cancerColonColon CarcinomaComplementComplementary DNAControl GroupsCrohn&aposs diseaseCytosolDataData AnalysesDevelopmentDiagnosticDietDiseaseDistalDown-RegulationEnsureExperimental ModelsFatty acid glycerol estersFelis catusFiltrationGenerationsGenetic ModelsGenetic TranscriptionGluconatesHarvestHumanIceImmunofluorescence ImmunologicIn VitroIncidenceIncubatedInflammatory Bowel DiseasesKineticsLiquid substanceMalignant NeoplasmsManufacturer NameMeasuresMediatingMembraneMessenger RNAMissouriModelingMolecularObesityPathogenesisPenicillinsPhenolsulfonphthaleinPlayPrecipitationProceduresProteinsProtocols documentationPublishingRNARNA purificationRNA-Directed DNA PolymeraseRNase protection assayRadioactivityRattusReactionRegulationResearch PersonnelRiskRisk FactorsRoleRunningSLC26A3 geneSalineSamplingScintillation CounterSecondary toSerumSodium ChlorideSodium Dextran SulfateSprague-Dawley RatsSterilityStreptomycinSystemTechniquesTemperatureThinnessTimeTissuesTrainingUlcerative ColitisUnited StatesUnited States National Institutes of HealthVesicleVisceral fatWaterWest VirginiaWestern BlottingZucker Ratsabsorptionadenomaapical membranebasebeta Actincolon cancer cell linecolon cancer riskdextran sulfate sodium induced colitisdiet-induced obesitydietary controldosagedrinking waterearly onset colon cancerexperimental groupexperimental studyextracellularin vitro Modelin vivoinhibitormRNA Expressionmortalitynonlinear regressionnovelobesity geneticsoligo (dT)potassium bicarbonateprotein expressionresponsesubcutaneoustime intervaluptake
项目摘要
Obesity has been associated with increased risk and early onset of colon cancer. About 40% of obesityrelated
cancer incidences were recorded in the United States. More specifically in West Virginia, 49% of
obesity-associated incidences of colon cancer and 18% of associated mortality rate have been
documented. Similarly, inflammatory bowel disease (IBD) (ulcerative colitis (UC) and Crohn’s disease
(CD)) is known to be an important risk factor for the development of colon cancer, namely colitis-associated
colon cancer (CAC). CAC is preceded by clinically detectable IBD. UC increases CAC risk up to 18-20%
while CD contributes up to 8% after 30 years of active disease. It has been demonstrated in the colon in an
in vivo genetic obesity model (Zucker rats) and in in vitro in Adipocyte Derived Secretome (ADS) model of
obesity that chloride absorption is mediated by the Cl-/HCO3- exchanger DRA was significantly decreased.
Similarly, in a rat model of colitis and in CAC, DRA was downregulated. This indicates that alteration of
regulation of chloride absorption is a common factor in both obesity and colon cancer models. However, if
downregulation of DRA mediated chloride absorption might specifically be responsible for the onset and
progression of obesity or colitis-associated colon cancer is not known. Therefore, we hypothesized that the
downregulation of Cl-/HCO3- exchanger DRA in colon in obesity or in colitis increases the risk of colon
cancer onset and progression. The overall aim of the proposed project is to determine the mechanism of
regulation of Cl-/HCO3- exchange in the colon in obesity and colitis mediated colon cancer. To decipher
this, a Zucker rat genetic model of obesity and colitis-associated colon cancer will be used. These animal
models will be used to induce colon cancer with DSS and Azoxymethane to determine the functional and
molecular mechanism of the regulation of DRA in obesity and colitis-associated colon cancer. Following will
be the specific aims of this proposal. Specific Aim 1: To Determine the mechanism of regulation of DRA in
the colon during obesity. Specific Aim 2: To Define the regulation of DRA in obesity mediated colon cancer.
Specific Aim 3: To Determine the mechanism of regulation of DRA in colitis during obesity. Specific Aim 4:
To Delineate the mechanism of regulation of DRA in colitis-associated colon cancer during obesity. This
proposal will indeed address the lacunae in the understanding of downregulation of DRA, which may play a
critical role in the pathogenesis of obesity, obesity-associated colon cancer, colitis and CAC. Successful
completion of these studies as a COBRE ACCORD investigator will provide the necessary training and
generation of preliminary data to compete for an NIH R01 and become an independent investigator.
肥胖与结肠癌的风险增加和早期发病有关。大约40%的肥胖相关
癌症发病率在美国记录在案。更具体地说,在西弗吉尼亚州,
与肥胖相关的结肠癌发病率和18%的相关死亡率,
记录在案。类似地,炎症性肠病(IBD)(溃疡性结肠炎(UC)和克罗恩病(Crohn's disease))也可用于治疗炎症性肠病(IBD)。
(CD))已知是结肠癌发展的重要危险因素,即结肠炎相关性
结肠癌(CAC)。CAC之前是临床可检测到的IBD。UC增加CAC风险高达18-20%
而CD在活动性疾病30年后贡献高达8%。它已被证明在结肠在一个
体内遗传性肥胖模型(Zucker大鼠)和体外脂肪细胞来源的分泌组(ADS)模型,
氯离子吸收由Cl-/HCO 3-交换剂介导的肥胖症显著降低。
类似地,在结肠炎大鼠模型和CAC中,p53表达下调。这表明,
氯化物吸收的调节是肥胖和结肠癌模型中的共同因素。但如果
降调节β-内酰胺介导的氯离子吸收可能是导致发病的具体原因,
肥胖或结肠炎相关结肠癌的进展尚不清楚。因此,我们假设,
肥胖或结肠炎患者结肠中Cl-/HCO 3-交换酶的下调会增加结肠炎的风险
癌症发作和进展。拟议项目的总体目标是确定
肥胖和结肠炎介导的结肠癌中结肠中Cl-/HCO 3-交换的调节。破译
为此,将使用肥胖和结肠炎相关结肠癌的Zucker大鼠遗传模型。这些动物
模型将用于用DSS和氧化偶氮甲烷诱导结肠癌,以确定功能和
肥胖症和结肠炎相关结肠癌中β-淀粉样蛋白调节的分子机制。以下人员
这是该提案的具体目标。具体目标1:确定调节胰岛素的机制
肥胖时的结肠具体目标2:确定肥胖介导的结肠癌中的调节。
具体目标3:确定DRA对肥胖期间结肠炎的调节机制。具体目标4:
探讨肥胖时结肠炎相关性结肠癌发生的调控机制。这
该提案确实将解决在理解降调节的缺陷,这可能会发挥
在肥胖、肥胖相关结肠癌、结肠炎和CAC的发病机制中起关键作用。成功
作为COBRE雅阁研究者完成这些研究后,将提供必要的培训,
生成初步数据,以竞争NIH R 01并成为独立研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Balasubramanian Palaniappan其他文献
Balasubramanian Palaniappan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Balasubramanian Palaniappan', 18)}}的其他基金
Mechanism of regulation of Down Regulated Adenoma (DRA) in obesity associated colitis induced colon cancer
下调腺瘤(DRA)在肥胖相关结肠炎诱发结肠癌中的调节机制
- 批准号:
10452801 - 财政年份:2020
- 资助金额:
$ 15.18万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.18万 - 项目类别:
Research Grant














{{item.name}}会员




